Published in AIDS Weekly, May 17th, 1999
A Dutch/Swedish/U.S. research team compared T-helper immune responses in groups of rhesus macaque monkeys given one of three different envelope-based HIV vaccines. The vaccines used the HIV-1SF2 gp120 envelope glycoprotein expressed in vivo via DNA immunization (gene-gun administered); delivered as a subunit protein with MF59 adjuvant; or incorporated into ISCOMs.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.